54 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Willamette Valley Vineyards, Inc. WVVI climbed 40.5% to $14.39.
• Dolphin Entertainment, Inc. DLPN shares gained 23.1% to $14.14. Dolphin Entertainment recently reported better-than-expected Q4 sales results.
• ShiftPixy, Inc. PIXY surged 22.5% to $3.075 as the company said it has been named as sponsor related to 4 SPACs.
• JAKKS Pacific, Inc. JAKK jumped 20% to $8.80 after the company reported better-than-expected Q1 results.
• Galera Therapeutics, Inc. GRTX gained 20% to $7.93 after the company announced updated results from its Phase 1/2 pilot trial of GC4419, versus placebo, in patients with locally advanced pancreatic cancer who are undergoing stereotactic body radiation therapy.
• 1-800-FLOWERS.COM, Inc. FLWS rose 18.1% to $29.31 after the company reported better-than-expected Q3 results.
• VEREIT, Inc. VER gained 17% to $48.29 after the company announced an all-stock merger agreement with Realty Income.
• MEDIROM Healthcare Technologies Inc. MRM gained 16.5% to $10.43.
• Ocular Therapeutix, Inc. OCUL surged 15.3% to $18.00. Ocular Therapeutix, reported multiple scientific presentations at the Association for Research in Vision and Ophthalmology Annual Meeting.
• Atossa Therapeutics, Inc. ATOS jumped 15% to $2.53.
• Communications Systems, Inc. JCS gained 14.6% to $6.74 as the company agreed to sell its Transition Networks and Net2Edge businesses to Lantronix.
• Realogy Holdings Corp. RLGY surged 14% to $17.39 following upbeat quarterly results.
• Vaxart, Inc. VXRT gained 13% to $9.52 as the company said its founder and chief scientific officer, Sean Tucker, Ph.D., will present at the World Vaccine Congress Washington that will be held virtually from May 4-6, 2021.
• AtriCure, Inc. ATRC surged 12.5% to $78.56 after the company reported that its EPi-Sense System was approved by the FDA for treatment of long-standing persistent afib patients.
• Capricor Therapeutics, Inc. CAPR shares climbed 11.9% to $4.42 after the company signed exclusive worldwide license agreement with Johns Hopkins University to include engineered exosomes for vaccines and therapeutics as part of the company's exosome technology portfolio.
• Extreme Networks, Inc. EXTR surged 10.5% to $11.81. The company recently reported better-than-expected Q3 results.
• Alliance Data Systems Corporation ADS gained 10.4% to $119.07 following upbeat Q1 results.
• Nokia Corporation NOK shares climbed 10.2% to $4.63 after reporting upbeat Q1 results.
• Bloomin' Brands, Inc. BLMN gained 9.3% to $31.48 after the company reported better-than-expected Q1 results.
• MRC Global Inc. MRC surged 8.8% to $9.86. The company recently released Q1 results.
• Cheesecake Factory Inc CAKE rose 6.3% to $62.69 after reporting higher quarterly earnings.
• Facebook, Inc. FB rose 6% to $325.49 after the company reported upbeat results for its first quarter on Wednesday. The company reported 1.88 billion daily active users, up 8% year-over-year, as well as 2.85 billion monthly active users, up 10% year-over-year.
• QUALCOMM Incorporated QCOM rose 4% to $142.03 after the company reported better-than-expected Q2 results and issued strong Q3 EPS guidance.

Check out these big penny stock gainers and losers

Losers

• Adverum Biotechnologies, Inc. ADVM shares dipped 60.4% to $4.0250 after the company announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.
• Farmmi, Inc. FAMI fell 56.3% to $0.3455 after the company priced its $42.0 million upsized underwritten public offering of ordinary shares.
• Cara Therapeutics, Inc. CARA fell 46% to $13.94 after the company announced mixed topline results from its KARE Phase 2 dose-ranging clinical trial of oral Korsuva for the treatment of moderate-to-severe pruritus in mild-to-severe atopic dermatitis patients. The company said the study did not meet the primary endpoint of worst-itch NRS change from baseline at week 12 or secondary endpoint of 4-point responder analysis in the intent-to-treat patient population. However, the study achieved primary endpoint of worst-itch NRS change and secondary endpoint of 4-point responder analysis in pre-specified analyses of mild-to-moderate AD patients, comprising 64% of ITT population.
• Atomera Incorporated ATOM fell 25.6% to $16.51 after the company reported Q1 earnings results.
• Brooklyn ImmunoTherapeutics, Inc. BTX dipped 24.8% to $32.86. Brooklyn ImmunoTherapeutics acquired license for mRNA technology platform of Factor Bioscience Limited And Novellus Therapeutics Limited.
• Impinj, Inc. PI dropped 20.6% to $46.10 after reporting a decline in quarterly earnings.
• Palisade Bio, Inc. PALI fell 19.9% to $8.22.
• Tiptree Inc. TIPT fell 19.5% to $10.10 after the company reported it has decided to withdraw the registration statement relating to previously announced IPO by Fortegra due to ‘prevailing market conditions and the high value.’
• Brightcove Inc. BCOV dropped 19.3% to $15.69 after the company issued Q2 EPS and sales guidance below estimates.
• FormFactor, Inc. FORM fell 19% to $38.73 after the company reported worse-than-expected Q1 EPS results.
• Selecta Biosciences, Inc. SELB dipped 18.3% to $3.175. Based on an internal strategic review and prioritization of its portfolio, Asklepios BioPharmaceutical Inc (AskBio) has decided to give all rights of methylmalonic acidemia (MMA) to Selecta Biosciences.
• Galectin Therapeutics Inc. GALT shares fell 17% to $4.2350 after jumping over 22% on Wednesday. The company recently announced neurosurgeon Dr. Ben Carson, Sr. joined the team as a special consultant to accelerate and enhance development of the company's galectin-3 inhibitor, belapectin.
• Vyant Bio, Inc. VYNT fell 16.7% to $3.8750 after climbing 16% on Wednesday. Vyant Bio, Ordaōs Bio and Cellaria, recently announced collaboration to 'design and qualify biomarker-specific small protein therapeutics.'
• MicroVision, Inc. MVIS dipped 15.7% to $17.69.
• 22nd Century Group, Inc. XXII fell 15.6% to $4.7201.
• Peabody Energy Corporation BTU dropped 15.3% to $3.6301 following quarterly results.
• Cohu, Inc. COHU dipped 14.2% to $40.15 after reporting Q1 results.
• Resolute Forest Products Inc. RFP dropped 13.8% to $13.40 after reporting preliminary Q1 results.
• Cree, Inc. CREE fell 13.6% to $97.31 after the company issued Q4 EPS guidance below analyst estimates. JP Morgan also downgraded the stock from Neutral to Underweight.
• Ribbon Communications Inc. RBBN dipped 13.5% to $7.03 following weak quarterly sales.
• Nemaura Medical Inc. NMRD dipped 12.6% to $4.73.
• eBay Inc. EBAY fell 11% to $55.47. eBay reported upbeat Q1 earnings, but issued weak earnings guidance for the current quarter.
• Teladoc Health, Inc. TDOC fell 9.8% to $168.03 after reporting Q1 results.
• Ford Motor Company F fell 9.6% to $11.23 after the company reported Q1 earnings results.
• Citrix Systems, Inc. CTXS dropped 9.4% to $125.49 after the company reported worse-than-expected Q1 results.
• Lyft, Inc. LYFT fell 8.5% to $57.96 on reports the US Labor Secretary said most US gig workers should be classified as employees.
• ServiceNow, Inc. NOW fell 8% to $512.87 after the company reported Q1 earnings results.
• Tenaris S.A. TS fell 7.9% to $20.86 after the company reported Q1 results.
• American Shared Hospital Services AMS dropped 7.9% to $2.4498.
• Hologic, Inc. HOLX fell 7.3% to $67.11 after the company reported worse-than-expected Q2 results and issued weak Q3 guidance.
• Ashford Hospitality Trust, Inc. AHT fell 7.2% to $2.31 after surging around 32% on Wednesday.